Argon Medical to pay $326.5 million cash for certain assets of Angiotech Pharma

VANCOUVER – Angiotech Pharmaceuticals, Inc., a Vancouver-based company that was formerly a major player in Canada’s biotechnology sector, has agreed to sell certain assets for $362.5 million in cash to Argon Medical Devices, Inc. Angiotech says the funds will be used repay all its outstanding debt. Angiotech’s stock was delisted from the Toronto and Nasdaq markets in early 2011 during a court-supervised restructuring. Previously, the company had commercial success with a process used in making devices for angioplasty heart surgeries.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.